UCB Looks To Its Next Wave Of Innovative Products

 
• By John Davis

Early clinical-stage products for neurological and autoimmune diseases are progressing through the European biopharma's pipeline.

Big breaking Ocean wave on a sandy beach on the north shore of Oahu Hawaii
UCB's R&D pipeline is progressing nicely • Source: Shutterstock

More from Immunological

More from Therapy Areas